Article Details

Cabaletta Bio Announces First Patient Dosed in Landmark DesCAARTes™ Trial of DSG3-CAART ...

Retrieved on: 2020-12-08 21:22:30

Tags for this article:

Click the tags to see associated articles and topics

Cabaletta Bio Announces First Patient Dosed in Landmark DesCAARTes™ Trial of DSG3-CAART .... View article details on hiswai:

Excerpt

... disease-causing autoantibodies while preserving the healthy <b>immune system</b>, provides mPV patients the potential of a deep and durable response, ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up